No matter how cynical the overall market is Editas Medicine Inc (EDIT) performance over the last week is recorded 27.51%

On November 17, 2023, Editas Medicine Inc (NASDAQ: EDIT) opened at $8.88, higher 11.39% from the last session. During the day, the shares moved up to $9.825 and dropped to $8.87 before settling in for the closing price of $8.78. Price fluctuations for EDIT have ranged from $6.08 to $11.93 over the past 52 weeks.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


A company in the Healthcare sector has jumped its sales by 68.84% annually for the last half of the decade. Company’s average yearly earnings per share was noted 24.65% at the time writing. With a float of $81.05 million, this company’s outstanding shares have now reached $81.67 million.

In an organization with 226 employees, it is important to assess its efficiency. In terms of profitability, gross margin is +67.85, operating margin of -1146.26, and the pretax margin is -1118.26.

Editas Medicine Inc (EDIT) Insider Updates

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Editas Medicine Inc is 0.77%, while institutional ownership is 77.41%. The most recent insider transaction that took place on Nov 14, was worth 5,706. In this transaction EVP, CBO AND CTO of this company sold 695 shares at a rate of $8.21, taking the stock ownership to the 74,894 shares. Before that another transaction happened on Nov 07, when Company’s EVP, CBO AND CTO sold 139 for $8.40, making the entire transaction worth $1,168. This insider now owns 75,589 shares in total.

Editas Medicine Inc (EDIT) Performance Highlights and Predictions

If we go through the results of last quarter, which was made public on 9/29/2023, the company posted -$0.55 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.57) by $0.02. This company achieved a net margin of -1118.26 while generating a return on equity of -48.22. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.6 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 24.65% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.70% during the next five years compared to -1.50% drop over the previous five years of trading.

Editas Medicine Inc (NASDAQ: EDIT) Trading Performance Indicators

Check out the current performance indicators for Editas Medicine Inc (EDIT). In the past quarter, the stock posted a quick ratio of 6.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 32.46.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.71, a number that is poised to hit -0.63 in the next quarter and is forecasted to reach -2.43 in one year’s time.

Technical Analysis of Editas Medicine Inc (EDIT)

Let’s dig in a bit further. During the last 5-days, its volume was 1.83 million. That was better than the volume of 1.81 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 88.11%. Additionally, its Average True Range was 0.59.

During the past 100 days, Editas Medicine Inc’s (EDIT) raw stochastic average was set at 98.80%, which indicates a significant increase from 98.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 100.39% in the past 14 days, which was higher than the 63.12% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $7.52, while its 200-day Moving Average is $8.46. However, in the short run, Editas Medicine Inc’s stock first resistance to watch stands at $10.11. Second resistance stands at $10.45. The third major resistance level sits at $11.07. If the price goes on to break the first support level at $9.16, it is likely to go to the next support level at $8.54. Assuming the price breaks the second support level, the third support level stands at $8.20.

Editas Medicine Inc (NASDAQ: EDIT) Key Stats

There are currently 81,674K shares outstanding in the company with a market cap of 798.73 million. Presently, the company’s annual sales total 19,710 K according to its annual income of -220,430 K. Last quarter, the company’s sales amounted to 5,340 K and its income totaled -45,020 K.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Can U.S. Bancorp.’s (USB) drop of -2.26% in a week be considered a lucky break?

U.S. Bancorp. (NYSE: USB) on November 27, 2023, started off the session at the price of $36.83, plunging -1.10% from the previous trading day....

Ambev S.A. ADR (ABEV) kicked off at the price of $2.76: Venture capitalists have an exciting new opportunity

November 27, 2023, Ambev S.A. ADR (NYSE: ABEV) trading session started at the price of $2.74, that was 0.36% jump from the session before....

Nikola Corp (NKLA) soared 0.48 in the last month: It’s impossible to believe the numbers

On November 27, 2023, Nikola Corp (NASDAQ: NKLA) opened at $0.9885, higher 0.48% from the last session. During the day, the shares moved up...


Please enter your comment!
Please enter your name here